Treatment of Gram-positive left-sided infective endocarditis with daptomycin

Journal of Infection and Chemotherapy

Volumn 19, Issue 4, 2013, Pages 698-702

  Kaya, Selçuk ^a   Yilmaz, Gürdal ^a   Kalkan, Ahmet ^a   Ertunç, Bariş ^a   Köksal, I'Ftihar ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Daptomycin; Infective endocarditis; Left sided

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; DAPTOMYCIN; GENTAMICIN; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CREATINE KINASE BLOOD LEVEL; DEATH; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEART FAILURE; HUMAN; KIDNEY FAILURE; LEFT SIDED INFECTIVE ENDOCARDITIS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; SIDE EFFECT; STREPTOCOCCUS MUTANS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DAPTOMYCIN; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 84882273207     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0546-9     Document Type: Article

References (20)

1. Cervera C, Castaneda X, Pericas JM, Del Río A, de la Maria CG, Mestres C, et al. Clinical utility of daptomycin in infective endocarditis caused by gram-positive cocci. Int J Antimicrob Agents. 2011;38:365-70. doi: 10.1016/j.ijantimicag.2010.11.038.
2. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463-73.
3. Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis. 2008;46:232-42.
4. Das I, Saluja T, Steeds R. Use of daptomycin in complicated cases of infective endocarditis. Eur J Clin Microbiol Infect Dis. 2011;30:807-12. doi: 10.1007/s10096-011-1160-y.
5. Elliot TSJ, Foweraker J, Gould FK, Perry JD. Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2004;54:971-81.
6. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 2009): the Task force on the Prevention, Diagnosis and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-413.
7. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis and Kwasaki Disease, Council on Cardiovascular Disease in the Young and the Councils on Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394-434.
8. LaPlante KL, Woodmansee S. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother. 2009;53:3880-6.
9. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM, et al. Relationship of MIC and bactericidal activity of efficacy of vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42:2398-402.
10. Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW, et al. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis. 2009;49:1169-74.
11. Rand KH, Houck HJ. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2004;48:2871-5.
12. Raad II, Hanna HA, Boktour M, Chaiban G, Hachem RY, Dvorak T, et al. Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm. Antimicrob Agents Chemother. 2005;49:5046-50.
13. Smith K, Perez A, Ramage G, Gemmell CG, Lang S. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents. 2009;33:374-8.
14. Levine DP. Clinical experience with daptomycin: bacteremia and endocarditis. J Antimicrob Chemother. 2008;62:35-9.
15. Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-65.
16. Levine DP, Lamp KC. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry. Am J Med. 2007;120:28-33.
17. Segreti JA, Crank CW, Finney MS. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy. 2006;26:347-52.
18. Sakoulas G, Alder J, Thauvin-Eilopoulos C, Moellering RC Jr, Eliopoulos GM. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother. 2006;50:1581-5.
19. Kalogeropoulos AS, Tsiodras S, Loverdos D, Fanourgiakis P, Skoutelis A. Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature. J Med Case Rep. 2011;5:13.
20. Doan TL, DePetrillo J, Singer C. Daptomycin-induced eosinophilia without pulmonary involvement. Am J Health Syst Pharm. 2010;67:2107-9.